We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORI icon
1026
Old Republic International
ORI
$10.4B
$1.26M 0.01%
+27,686
New +$1.2M
MC icon
1027
Moelis & Co
MC
$4.94B
$1.26M 0.01%
18,377
-43,928
-71% -$2.93M
TMUS icon
1028
CALL
T-Mobile US
TMUS
$190B
$1.26M 0.01%
6,200
TMUS icon
1029
PUT
T-Mobile US
TMUS
$190B
$1.26M 0.01%
6,200
DSGX icon
1030
Descartes Systems
DSGX
$6.82B
$1.26M 0.01%
14,340
+1,274
+10% +$114K
REYN icon
1031
Reynolds Consumer Products
REYN
$5.59B
$1.25M 0.01%
+54,668
New +$1.32M
INDV icon
1032
Indivior Pharmaceuticals
INDV
$4.58B
$1.25M 0.01%
34,835
-1,297
-4% -$39.6K
HAL icon
1033
Halliburton
HAL
$26.6B
$1.25M 0.01%
+44,164
New +$1.17M
WSO icon
1034
Watsco Inc
WSO
$13.6B
$1.25M 0.01%
3,696
-11,193
-75% -$4M
LUNR icon
1035
Intuitive Machines
LUNR
$2.63B
$1.24M 0.01%
76,531
-34,329
-31% -$398K
CEPT
1036
DELISTED
Cantor Equity Partners II
CEPT
$1.24M 0.01%
110,000
-12,366
-10% -$140K
XPRO icon
1037
Expro Ltd
XPRO
$1.91B
$1.23M 0.01%
+92,473
New +$1.25M
MHK icon
1038
Mohawk Industries
MHK
$9.22B
$1.23M 0.01%
11,277
-107,599
-91% -$12.4M
CAT icon
1039
Caterpillar
CAT
$387B
$1.23M 0.01%
2,150
-56,260
-96% -$31.3M
AGNC icon
1040
AGNC Investment
AGNC
$12.9B
$1.23M 0.01%
114,777
-1,816,266
-94% -$18.7M
NTRS icon
1041
Northern Trust
NTRS
$33.9B
$1.23M 0.01%
9,008
-35,206
-80% -$4.62M
AR icon
1042
Antero Resources
AR
$10.7B
$1.22M 0.01%
35,543
-25,535
-42% -$865K
IFS icon
1043
Intercorp Financial Services
IFS
$6.55B
$1.22M 0.01%
28,819
+8,713
+43% +$358K
ATRO icon
1044
Astronics
ATRO
$3.84B
$1.22M 0.01%
27,000
-528,731
-95% -$22.2M
BFAM icon
1045
Bright Horizons
BFAM
$3.86B
$1.22M 0.01%
12,021
-66,461
-85% -$6.7M
OACC
1046
Oaktree Acquisition Corp III Life Sciences
OACC
$1.22M 0.01%
115,174
-9,826
-8% -$104K
NWAX.U
1047
New America Acquisition I Corp Units
NWAX.U
$1.22M 0.01%
+116,749
New +$1.21M
FDMT icon
1048
4D Molecular Therapeutics
FDMT
$562M
$1.21M 0.01%
161,982
-17,093
-10% -$173K
GBDC icon
1049
Golub Capital BDC
GBDC
$3.42B
$1.21M 0.01%
+89,202
New +$1.24M
OPRX icon
1050
OptimizeRx
OPRX
$133M
$1.2M 0.01%
98,170
+36,522
+59% +$597K

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.